retatrutide fda approval 2025 Weight Loss Results:Trial Data and Status Retatrutide Promises Big Weight Loss,

Description

Although safe for long-term use, weight loss results are modest, and gastrointestinal side effects such as oily stools and diarrhoea are common

Retatrutide could improve blood sugar control and assuage risks associated with metabolic disorders, such as cardiovascular complications

Simultaneously, it suppresses glucagon secretion from pancreatic alpha cells, reducing hepatic glucose production

Overall, for covered workers in plans with a general annual deductible, the average deductible for single coverage at firms with 10 to 199 workers ($2,631) is higher than the average deductible at larger firms ($1,670) [Figure 7.3]

Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea